For the year ending 2025-12-31, NRXS made $3,569,282 in revenue. -$8,615,152 in net income. Net profit margin of -241.37%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Net sales | 3,569,282 | |||
| Cost of goods sold | 562,916 | |||
| Gross profit | 3,006,366 | |||
| Selling expenses | 2,279,974 | |||
| Research and development | 493,611 | |||
| General and administrative | 8,062,689 | |||
| Operating loss | -7,829,908 | |||
| Financing charges | 30,240 | |||
| Interest expense | 73,969 | |||
| Change in fair value of warrant liability | 7,634 | |||
| Other income | 141,196 | |||
| Total other income (expense), net | 29,353 | |||
| Net loss | -7,800,555 | |||
| Preferred stock dividends | 814,597 | |||
| Net loss available to common stockholders | -8,615,152 | |||
| Basic EPS | -0.95 | |||
| Diluted EPS | -0.95 | |||
| Basic Average Shares | 9,083,399 | |||
| Diluted Average Shares | 9,083,399 | |||
Neuraxis, INC (NRXS)
Neuraxis, INC (NRXS)